Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

Professor of Medicine, Division of Infectious Diseases
University of Colorado School of Medicine
Director, University of Colorado HIV/AIDS Clinical Program
Anschutz Medical Campus
Aurora, Colorado

Topics of Professional Interest:
  • Clinical outcomes in HIV care
  • Antiretroviral therapy
  • Clinical research updates
  • Indications and limitations of antiretroviral therapy
  • Opportunistic infection management
Current Professional Summary:

Dr Johnson is Director of the Infectious Disease Group Practice and HIV/AIDS Clinical Program at the University of Colorado Hospital in Aurora, Colorado. He is a Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at the University of Colorado School of Medicine.

Committees and Organizations:
  • Director, Infectious Disease Group Practice, University Hospital
  • Member, Denver Ryan White Planning Council Priorities Committee
  • Medical Director, Mountain-Plains AIDS Education and Training Center
  • Member, HIVQUAL Advisory Committee
  • Fellow, American College of Physicians
  • Fellow, Infectious Diseases Society of America
Honors and Awards:
  • Denver's Top Doctors (Multiple years, 2001-2010)
  • Outstanding Physician of the Year, University of Colorado Hospital (2006)
  • Infectious Disease Fellowship Teaching Award (2000)
  • President's Award for Outstanding Clinical Service, University of Colorado Hospital (1998)
  • Elected to Fellowship, American College of Physicians (1994)
Education:
  • Bethany College, BA (1980)
  • Northwestern University, MD (1984)
  • Fitzsimons Army Medical Center, Residency, Internal Medicine (1984-1987)
  • Walter Reed Army Medical Center, Fellowship, Infectious Diseases (1987-1990)
Selected Publications:
  1. Johnson SC. Syphilis. In: Rakel RE, Bope ET, eds. Conn's Current Therapy. 53rd ed. Philadelphia, PA: W.B. Saunders; 2001:770-772.
  2. Johnson SC, Benson CA, Johnson DW, Weinberg A. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution. Clin Infect Dis. 2001;32:815-819.
  3. Johnson SC, Gerber JG. Advances in HIV/AIDS therapy. Adv Intern Med. 2000;45:1-40.
  4. Williams WJ, Johnson SC. Syphilis. In: Edlich RF, ed. Advances in Medicine. Arlington, VA: ABI Professional Publications; 2000:168-172.
  5. Young B, Johnson S, Bahktiari M, et al. Resistance mutations in protease and reverse transcriptase genes of human immunodeficiency virus type 1 isolates from patients with combination antiretroviral therapy failure. J Infect Dis. 1998;178:1497-1501.
  6. Akler ME, Johnson DW, Burman WJ, Johnson SC. Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis. Ophthalmology. 1998;105:651-657.
  7. Aronson NE, Wortmann GW, Johnson SC, et al. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis. 1998;27:1457-1464.
  8. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med. 1997;337:307-314.
  9. Magill AJ, Grogl M, Johnson SC, Gasser RA Jr. Visceral infection due to Leishmania tropica in a veteran of Operation Desert Storm who presented 2 years after leaving Saudi Arabia. Clin Infect Dis. 1994;19:805-806.
  10. Teel LD, Finelli MR, Johnson SC.Isolation of Mycoplasma species from bronchoalveolar lavages of patients positive and negative for human immunodeficiency virus. J Clin Microbiol. 1994;32:1387-1389.

Presentations

An Advanced CME Live Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management